Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.06.12.597764

Automatic sleep scoring for real-time monitoring and stimulation in individuals with and without sleep apnea

Abstract

Digital therapeutics, enabled by advanced machine learning algorithms and medical wearable devices, offer a promising approach to streamline diagnostics and improve access to healthcare. Within this framework, automatic sleep scoring can provide accurate and efficient sleep analysis from electrophysiological signals recorded with wearable sensors, such as electroencephalography (EEG). However, the optimal configuration and temporal dynamics of automatic sleep scoring systems remain unclear, especially concerning their performance across different population samples. This study systematically investigates the impact of electrode setup, temporal scope, and population characteristics on the performance of automatic sleep scoring algorithms. Utilizing a convolutional neural network (CNN) model, we analyzed various electrode configurations and temporal dynamics using datasets comprising both healthy participants and individuals with sleep apnea. Our findings reveal that sleep scoring based on a single frontal EEG channel demonstrates reliable congruency with human expert scorers, with minimal improvement observed with additional sensors. Moreover, we demonstrate that real-time sleep scoring can be achieved with comparable accuracy to offline methods, which rely on past and future information to classify a window of interest. Remarkably, a notable reduction in decoding accuracy is observed for individuals with sleep disorders compared to healthy participants, highlighting the challenges inherent in accurately assessing sleep stages in clinical populations. Digital solutions for automatic sleep scoring hold promise for facilitating timely diagnoses and personalized treatment plans, with applications extending beyond sleep analysis to include closed-loop neurostimulation interventions. Our findings provide valuable insights into the complexities of automatic sleep scoring and offer considerations for the development of effective and efficient sleep assessment tools in both clinical and research settings.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Esparza-Iaizzo, M., Sierra-Torralba, M., Klinzing, J. G., Minguez, J., Montesano, L., Lopez-Larraz, E.. 2024-06-13. Automatic sleep scoring for real-time monitoring and stimulation in individuals with and without sleep apnea. https://doi.org/10.1101/2024.06.12.597764

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗